Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
https://www.eurasiamining.co.uk/investors/aim-rule-26
I wont lie jumped back in EUA today as see this as a great investment now that is only going one way.
Will keep adding when funds allow as watching from a far this leadership team are fantastic.
Across 16 trades all posted at once
Boom
That would be epic, I also like a Thursday 7am.
What a great couple days, feels like engine sonly just warming up.
Just think new asset class with Global scale
GLA ho ho ho merryIMchristmas
Ho ho ho
Happy Christmas everybody
With the article published last night from Nicola basically advertising Inventory Monetization what we all waiting for !!
https://www.globalbankingandfinance.com/how-inventory-monetisation-and-blockchain-could-alleviate-supply-chain-pressures/
18 months of delays due to the ecosystem, funders, Sace, covid all taking its time.
We have a team now and everything looks good to go.
Good luck to all my LTH friends
Del x
Nice to see some upward movement, where is Don of D***s today
Oh he back in his hole.
Merry Christmas LTH hope 2022 is prosperous for us all x
General finance - Milan
Money paid Bny- Milan
Banco Ankro - securitisation specialists (banco bpm group)
Syme -Milan
£75m initial amount could lead to lower revenue as forecast
Lots links to Italy and supporting distressed sme
Sace insure upto 90% loans so less risk
Why did Revs get changed as funder wanted to pick sace customers
Why would they use an Italian vehicle ?
Shariah won’t be syme be intesa ?
As part of the securitisation- which will not result in a deconsolidation of the receivables to customers which will therefore continue to be recorded on the factors balance sheet.
BNP
Greenfinance
Banca Akros
Have a good look please as feel this is an IM ?
First PDF Three year securitization program
https://www.generalfinance.it/press-releases/?lang=en
Possible IM ?????
1p get on it
There not be careful
awesome news
Hello 1m buyer boom
AZD1656 is a potent and selective activator of glucokinase that was being
developed by AZN for type II diabetes. SGSC recognised that the effects of
AZD1656 on immune function might be useful to treat people with diabetes that
had become infected with COVID-19. This was confirmed during 2021, with
encouraging results in a Phase II clinical trial, known as ARCADIA, in 150 patients
with either type I or type II diabetes, who were hospitalised with mild-to-moderate
COVID-19. There was a strong trend towards reduced mortality in patients
receiving AZD1656. Data from ARCADIA support the continued investigation of
AZD1656 for the treatment of patients with COVID-19, with or without diabetes,
and SGSC is now considering its options to progress AZD1656 through a Phase III
trial.
This seems a bit different
Interesting be nice see an RNS this afternoon with an arcadia update or any time in next few weeks, due to attention on covid
(Get it out there help smash this S*** virus)
GLA
https://www.investegate.co.uk/article.aspx?id=202110220700028733P
As announced on 20 September 2021, Cizzle Biotechnology signed an agreement with SGSC to grant Cizzle Biotechnology potential future royalty payments from the commercialisation of St George Street's therapeutic asset AZD1656 of up to £5 million. This followed SGSC's announcement on 9 September 2021 of encouraging clinical trial results arising from their existing collaboration with AstraZeneca and funded by international investment through Excalibur Medicines Ltd and an HM Government grant through the UKRI/Innovate UK programme.
This new commercial contract with SGSC will seek to provide valuable diagnostic information on patients based on the proposed mechanism of action of AZD1656 which may be linked to the regulation of inflammation through activating migration of T regulatory cells to sites of damaging inflammation. Migration of T regulatory cells amplify the body's own mechanism of damping down an inappropriate inflammatory overreaction and hence may have important clinical benefits in managing autoimmune disease.
https://www.ucl.ac.uk/news/2021/sep/new-covid-19-treatment-patients-diabetes-shows-early-promise
Nice read from Sep 21
We on the right blockchain systems
Could be any of the 80 global banks on there.
R3, Contour, Epic Sim(Azimut Direct)
Why the wait ?
Brand new asset class, legislation, Covid.
Patience is key to this. GLA when you play with the big boys remember they start the music when they ready :-)